The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the prospective PETAML trial

Extramedullary (EM) disease in patients with acute myeloid leukemia (AML) is a known phenomenon. Since the prevalence of EM AML has so far only been clinically determined on examination, we performed a prospective study in patients with AML. The aim of the study was to determine the prevalence of me...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Friedrich Stölzel, Tors Lüer, Steffen Löck, Stefani Parmentier, Friederike Kuithan, Michael Kramer, Nael S. Alakel, Katja Sockel, Franziska Taube, Jan M. Middeke, Johannes Schetelig, Christoph Röllig, Tobias Paulus, Jörg Kotzerke, Gerhard Ehninger, Martin Bornhäuser, Markus Schaich, Klaus Zoephel
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Ferrata Storti Foundation 2020-06-01
سلاسل:	Haematologica
الوصول للمادة أونلاين:	https://haematologica.org/article/view/9430
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!